C4 Therapeutics, Inc.
USD4.87
+0.52 (+11.84%)
CEO
Andrew J. Hirsch
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.35
Prev. Close
$4.35
Day Low
$4.33
Day High
$5.17
52W Low
$1.40
52W High
$5.17
Market Cap
$0.40B
Volume
4.57M
| -2.4 |
| 31 Dec 2023 | FY | 62.7% | -638.3% | -53.8% | -35.2% | 0.29 | 6.34 | -2.1 |
| 31 Dec 2022 | FY | 100.0% | -412.2% | -44.3% | -29.8% | 0.30 | 6.46 | -2.2 |
| 31 Dec 2021 | FY | 100.0% | -183.2% | -21.5% | -16.6% | 0.11 | 6.36 | -17.7 |
| 31 Dec 2020 | FY | -136.3% | -199.8% | -23.6% | -16.6% | 0.08 | 8.69 | -21.5 |
| 31 Dec 2019 | FY | 100.0% | -159.5% | 30.5% | -28.8% | -0.12 | 2.88 | -32.1 |
| 31 Dec 2018 | FY | -47.7% | -81.1% | 19.7% | -10.7% | -0.18 | 5.16 | -24.0 |
| -2.7 |
| 30 Sept 2025 | Q3 | 100.0% | -286.4% | -20.8% | -12.1% | 0.40 | 5.76 | -1.3 |
| 30 Jun 2025 | Q2 | 100.0% | -402.6% | -14.9% | -8.8% | 0.36 | 5.06 | -1.0 |
| 31 Mar 2025 | Q1 | 100.0% | -363.7% | -13.5% | -8.2% | 0.33 | 5.70 | -1.1 |
| 31 Dec 2024 | Q4 | 65.9% | -667.8% | -16.0% | -9.9% | 0.30 | 5.71 | -1.8 |
| 30 Sept 2024 | Q3 | 86.6% | -160.6% | -10.2% | -6.6% | 0.28 | 6.31 | -4.0 |
| 30 Jun 2024 | Q2 | 83.0% | -147.6% | -7.2% | -4.6% | 0.28 | 5.09 | -4.7 |
| 31 Mar 2024 | Q1 | 100.0% | -933.2% | -11.0% | -7.1% | 0.27 | 5.08 | -4.9 |
| 31 Dec 2023 | Q4 | 48.1% | -1065.7% | -14.1% | -9.2% | 0.29 | 6.34 | -2.1 |